Photodynamic inactivation of Aeromonas hydrophila by cationic phthalocyanines with different hydrophobicity

Veselin Kussovski1, Vanya Mantareva, Ivan Angelov

  • 1Department of Pathogenic Bacteria, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, Bulgaria. vkussovski@yahoo.com

Insights

This study synthesized novel cationic phthalocyanines for antibacterial photodynamic therapy. A specific phthalocyanine derivative demonstrated potent inactivation of multidrug-resistant Aeromonas hydrophila with optimized light and drug parameters.

Area of Science:

  • Photochemistry
  • Microbiology
  • Materials Science

Background:

  • Antibacterial photodynamic therapy (aPDT) offers a promising alternative for combating pathogenic bacteria.
  • Multidrug-resistant Aeromonas hydrophila poses a significant threat to human and animal health.
  • Phthalocyanines are effective photosensitizers for aPDT.

Discussion:

  • Synthesized tetra alkyl-substituted cationic phthalocyanines with varying pyridyloxy substituents.
  • Investigated the antibacterial efficacy of these sensitizers against Aeromonas hydrophila.
  • Observed decreased phthalocyanine uptake with increased bacterial cell density.
  • Enhanced cellular accumulation of phthalocyanines with increased hydrophobicity.

Key Insights:

  • A phthalocyanine derivative with (methoxy) pyridyloxy substitution achieved complete bacterial inactivation.
  • Optimal inactivation was correlated with short exposure times, low drug concentrations, and mild irradiation.
  • The C12-substituted phthalocyanine exhibited some dark toxicity but significant phototoxicity under optimal conditions.

Outlook:

  • Further research into structure-activity relationships of phthalocyanines for enhanced aPDT.
  • Potential development of targeted aPDT strategies for multidrug-resistant infections.
  • Exploration of phthalocyanine-based therapies for diverse bacterial pathogens.